Have you heard of Tirzepatide? If you haven’t, I’m certain you will be hearing about it soon.

Because Tirzepatide (trade name Mounjaro), is finally now available at pharmacies in Canada. We have been waiting a year due to the global shortages of this medication.

Tirzepatide is a GIP/GLP1 dual agonist. It is very effective for improving blood sugar control and helping people with type 2 diabetes and obesity lose weight. This medication has shown outstanding blood sugar control and weight loss results according to the trials.

I’m Dr. Sasha High, an obesity physician practicing since 2012. I’m one of the leading Canadian physicians in obesity and in this podcast episode, I answer all your curious questions about this new treatment for obesity including:

References:

FOLLOW SASHA 
Instagram - https://www.instagram.com/sashahighmd/
Tiktok - https://www.tiktok.com/@sashahighmd